Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease;Valor de los contrastes ecográficos en el diagnóstico de hepatocarcinoma en lesiones ocupantes de espacio detectadas en pacientes con hepatopatía

Gastroenterologia y Hepatologia

Volumn 30, Issue 7, 2007, Pages 381-386

  Gómez Rodríguez, Rafael Ángel ^a   Varasa, Tomás Artaza ^a   De Frutos, Concepción González ^a   Ruano, Juan José Sánchez ^a   Ortega, Alejandro Repiso ^a   Macías, María José Pérez Grueso ^a   Rosas, Concepción Muñoz ^a   Jiménez, José María Carrobles ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER INJURY; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 34548652352     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1157/13108811     Document Type: Article

References (23)

1. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulseinversion harmonic US. Radiology. 2000;216:411-7.
2. Harvey CJ, AlbrechtT. Ultrasound of focal liver lesions. Eur Radiol. 2001;11:1578-93.
3. Gómez R, González C, Artaza T. Avances con el uso de contrastes en ecografía digestiva. Rev Esp Enferm Dig. 2005;97 Supl 2:98-107.
4. Giorgio A, Ferraioli G, Tarantino L, De Stefano G, Scala V, Scarano F, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrosis: comparison with contrast-enhanced helical CT appearance. AJR. 2004;183:1319-26.
5. Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, et al. Uselfulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol. 2004;41:421-6.
6. Quaia E, Callida F, Bertolotto M, Rossi S, Garioni L, Rosa L, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004;232:420-30.
7. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27-34.
8. Albrecht T, Hohmann J, Oldenburg A, Skrok J, Wolf KJ. Detection and characterization of liver metastasis. Eur Radiol. 2004;14 Suppl 8:25-33.
9. Ding H, Wang W, Huang BJ, Wei RX, He NA, Qi Q, et al. Imaging of focal liver lesions. Low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med. 2005;24:285-97.
10. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulphur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound. 2006;34:261-72.
11. Dietrich Ch F. Characterization of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol. 2004;51 Suppl: 9-17.
12. Nicolau C, Vilana R, Brú C. The use of the contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HC. Eur Radiol. 2004;14 Suppl:63-71.
13. Catalano O, Lobianco R, Cusati B, Siani A. Hepatocellular carcinoma: spectrum of contrast-enhanced gray-scale harmonic sonography findings. Abdom Imaging. 2004;29:341-7.
14. Nicolau C, Catala V, Vilana R, Gilabert R, Bianchi L, Sole M, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol. 2004;14:1092-9.
15. Takayasu K, Shima Y, Muramatsu Y, Goto H, Moriyama M, Yamada T, et al. Angiography of small hepatocellular carcinoma: análisis of 105 resected tumours. Am J Roentgenol. 1986;147:525-9.
16. Fan ZH, Chen MH, Dai Y, Wang YB, Yan K, Wu W, et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR. 2006;186:1512-9.
17. Quaia E, Palumbo A, Rossi S, Degobbis F, Cernic S, Tona G, et al. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR. 2006;186:1560-70.
18. Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue. Differentiation between benign and malignant hepatic lesions. J Ultrasound Med. 2004;23:1557-68.
19. Longchampt E, Patriarche C, Fabre M. Accuracy of citology vs microbiopsy for the diagnosis of well-diferentiated hepatocellular carcinoma and macroregenerative nodule: definition of standardized criteria from a study of 100 cases. Acta Cytol. 2000;44:515-23.
20. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology. 2002;225:143-9.
21. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR. 2006;186:1551-9.
22. Bleuzen A, Tranquart. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol. 2004;14 Suppl 8:53-62.
23. Kudo M. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Intervirology. 2004;47:227-37.